Finerenone in Patients with a Recent Worsening Heart Failure Event: the FINEARTS-HF Trial.

Akshay S. Desai,Muthiah Vaduganathan,Brian L. Claggett,Ian J. Kulac,Pardeep S. Jhund,Jonathan Cunningham,Maria Borentain,James Lay-Flurrie,Prabhakar Viswanathan,Katja Rohwedder, Flaviana Amarante,Carolyn S. P. Lam,Michele Senni,Sanjiv J. Shah,Adriaan A. Voors,Faiez Zannad,Bertram Pitt,Mikhail Kosiborod,John J. V. McMurray,Scott D. Solomon

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2025）

Cited 0|Views3

Key words

KEY WORDS clinical trial,finerenone,heart failure,heart failure with mildly reduced ejection fraction,heart failure with preserved ejection fraction,mineralocorticoid receptor antagonist,worsening heart failure

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined